Cristina Bucelli Selected Research

Hemostatics (Antihemorrhagics)

12/2016

CD18 promoter methylation is associated with a higher risk of thrombotic complications in primary myelofibrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cristina Bucelli Research Topics

Disease

20	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2024 - 10/2015
8	Primary Myelofibrosis (Myelosclerosis) 01/2023 - 04/2017
7	Neoplasms (Cancer) 10/2023 - 12/2016
3	Blast Crisis (Blast Phase) 11/2023 - 01/2017
3	Pleural Effusion (Pleural Effusions) 01/2022 - 01/2018
3	Essential Thrombocythemia 01/2022 - 06/2016
3	Fibrosis (Cirrhosis) 01/2021 - 12/2017
2	Polycythemia Vera 06/2023 - 08/2020
2	Thrombocytopenia (Thrombopenia) 02/2021 - 12/2017
1	Disease Progression 11/2023
1	Eosinophilia 10/2023
1	Lymphomatoid Papulosis 10/2023
1	Hypertension (High Blood Pressure) 01/2023
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2023
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2023
1	Stroke (Strokes) 01/2023
1	Lymphoma (Lymphomas) 01/2022
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022
1	Iron Overload 01/2022
1	Anemia 02/2021
1	Systemic Mastocytosis 01/2021
1	Edema (Dropsy) 09/2020
1	Muscle Cramp (Cramp) 09/2020
1	Fatigue 09/2020
1	Diarrhea 09/2020
1	COVID-19 07/2020
1	Splenomegaly 01/2018
1	Osteosclerosis 12/2017
1	Hyperplasia 11/2017
1	Pulmonary Hypertension 04/2017
1	Ischemic Stroke 01/2017
1	Thrombosis (Thrombus) 12/2016
1	Leukemia 06/2016
1	Diabetes Mellitus 10/2015
1	Insulin Resistance 10/2015
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2015

Drug/Important Bio-Agent (IBA)

13	Tyrosine Kinase InhibitorsIBA 01/2024 - 10/2015
8	Imatinib Mesylate (Gleevec)FDA Link 10/2023 - 10/2015
7	Dasatinib (BMS 354825)FDA Link 01/2023 - 10/2015
5	nilotinib FDA Link 01/2023 - 10/2015
4	ruxolitinibIBA 01/2023 - 01/2018
3	Reticulin (Reticular Fiber)IBA 01/2021 - 12/2017
3	ponatinibIBA 10/2020 - 01/2017
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2023 - 01/2019
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 01/2020
2	amsonic acid (DAS)IBA 11/2021 - 01/2018
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 02/2021 - 12/2017
2	CollagenIBA 01/2018 - 12/2017
1	Deferasirox FDA Link 01/2022
1	venetoclaxIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	ThromboxanesIBA 01/2022
1	COVID-19 VaccinesIBA 11/2021
1	OMS 2017IBA 02/2021
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2019
1	Oncogene Proteins (Oncogene Protein)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 04/2017
1	IntegrinsIBA 12/2016
1	Hemostatics (Antihemorrhagics)IBA 12/2016
1	anagrelide (Agrylin)FDA LinkGeneric 06/2016
1	CalreticulinIBA 06/2016
1	C-PeptideIBA 10/2015
1	Glucose (Dextrose)FDA LinkGeneric 10/2015
1	Insulin (Novolin)FDA Link 10/2015
1	LDL CholesterolIBA 10/2015

Therapy/Procedure

11	Therapeutics 06/2023 - 10/2015
1	Aftercare (After-Treatment) 11/2023
1	Continuity of Patient Care 07/2020
1	Transplantation 01/2017
1	Drug Therapy (Chemotherapy) 01/2017
1	Polypharmacy 11/2016